Laman Utama500660 • BOM
add
GlaxoSmithKline Pharmaceuticals Ltd
Tutup sebelumnya
₹3,298.05
Julat hari
₹3,272.00 - ₹3,313.25
Julat tahun
₹1,924.30 - ₹3,515.95
Permodalan pasaran
560.56B INR
Bilangan Purata
8.93K
Nisbah P/E
60.38
Hasil dividen
1.27%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 9.74B | 4.79% |
Perbelanjaan pengendalian | 2.77B | -8.47% |
Pendapatan bersih | 2.63B | 35.17% |
Margin untung bersih | 26.98 | 28.97% |
Pendapatan bagi setiap syer | 54.52 | — |
EBITDA | 3.32B | 32.98% |
Kadar cukai berkesan | 26.69% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 24.98B | 34.54% |
Jumlah aset | 41.08B | 15.50% |
Jumlah liabiliti | 21.57B | 21.24% |
Jumlah ekuiti | 19.51B | — |
Syer tertunggak | 169.41J | — |
Harga kepada buku | 28.63 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 44.16% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 2.63B | 35.17% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Diasaskan
13 Nov 1924
Tapak web
Pekerja
3,113
